Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma

NCT04076579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Sarcoma Metastatic

Interventions

DRUG: Olaparib
DRUG: Trabectedin

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]
[object Object]